Published in J Virol on April 01, 2001
Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol (2007) 2.46
Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells. J Virol (2005) 2.00
A viral RNA structural element alters host recognition of nonself RNA. Science (2014) 1.71
Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses. J Virol (2006) 1.57
An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector. J Virol (2003) 1.56
Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus. J Virol (2005) 1.53
The efficient packaging of Venezuelan equine encephalitis virus-specific RNAs into viral particles is determined by nsP1-3 synthesis. Virology (2005) 1.51
Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis. J Virol (2008) 1.48
Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence. J Virol (2008) 1.36
Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression. J Virol (2007) 1.35
An attenuating mutation in nsP1 of the Sindbis-group virus S.A.AR86 accelerates nonstructural protein processing and up-regulates viral 26S RNA synthesis. J Virol (2003) 1.35
Early events in the pathogenesis of eastern equine encephalitis virus in mice. Am J Pathol (2005) 1.27
Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats. J Virol (2007) 1.24
Selection of functional 5' cis-acting elements promoting efficient sindbis virus genome replication. J Virol (2004) 1.23
Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system. J Virol (2007) 1.21
IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells. Virology (2008) 1.20
Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff. J Virol (2009) 1.19
Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein. J Virol (2010) 1.10
Characteristics of alpha/beta interferon induction after infection of murine fibroblasts with wild-type and mutant alphaviruses. Virology (2009) 1.08
A determinant of Sindbis virus neurovirulence enables efficient disruption of Jak/STAT signaling. J Virol (2010) 1.05
The 5'UTR-specific mutation in VEEV TC-83 genome has a strong effect on RNA replication and subgenomic RNA synthesis, but not on translation of the encoded proteins. Virology (2009) 1.04
C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Res (2008) 1.04
Sendai virus infection induces efficient adaptive immunity independently of type I interferons. J Virol (2006) 1.03
Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design. PLoS Negl Trop Dis (2014) 1.02
Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells. J Virol (2008) 1.02
The role of the blood-brain barrier during Venezuelan equine encephalitis virus infection. J Virol (2011) 1.01
Random insertion mutagenesis of sindbis virus nonstructural protein 2 and selection of variants incapable of downregulating cellular transcription. J Virol (2009) 0.99
A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation. Vaccine (2012) 0.98
Toll-like receptor-independent triggering of dendritic cell maturation by viruses. J Virol (2006) 0.97
Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine. Antiviral Res (2008) 0.97
Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins. Virology (2007) 0.97
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice. Vaccine (2007) 0.97
Alpha/beta interferon inhibits cap-dependent translation of viral but not cellular mRNA by a PKR-independent mechanism. J Virol (2007) 0.96
An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice. J Virol (2007) 0.95
Innate immune restriction and antagonism of viral RNA lacking 2׳-O methylation. Virology (2015) 0.95
A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo. PLoS Pathog (2007) 0.95
T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody. J Virol (2010) 0.93
Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge. J Virol (2009) 0.92
Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis. J Virol (2009) 0.91
Venezuelan equine encephalitis virus infection causes modulation of inflammatory and immune response genes in mouse brain. BMC Genomics (2008) 0.90
Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis. Neurotherapeutics (2016) 0.89
Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine. J Virol (2007) 0.88
Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles. Vaccine (2012) 0.88
Antiviral type I and type III interferon responses in the central nervous system. Viruses (2013) 0.88
Early events in alphavirus replication determine the outcome of infection. J Virol (2012) 0.88
Structural and functional elements of the promoter encoded by the 5' untranslated region of the Venezuelan equine encephalitis virus genome. J Virol (2009) 0.88
IFIT1 Differentially Interferes with Translation and Replication of Alphavirus Genomes and Promotes Induction of Type I Interferon. PLoS Pathog (2015) 0.87
Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model. Virology (2010) 0.87
Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice. J Virol (2013) 0.84
Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats. PLoS One (2008) 0.84
Natural killer cell mediated pathogenesis determines outcome of central nervous system infection with Venezuelan equine encephalitis virus in C3H/HeN mice. Vaccine (2012) 0.83
Myd88-dependent toll-like receptor 7 signaling mediates protection from severe Ross River virus-induced disease in mice. J Virol (2012) 0.83
Activation of the type I interferon pathway is enhanced in response to human neuronal differentiation. PLoS One (2013) 0.82
Differentiation of neurons restricts Arbovirus replication and increases expression of the alpha isoform of IRF-7. J Virol (2014) 0.82
Both RIG-I and MDA5 detect alphavirus replication in concentration-dependent mode. Virology (2015) 0.80
Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection. J Virol (2014) 0.80
An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo. Virology (2012) 0.80
Early activation of the host complement system is required to restrict central nervous system invasion and limit neuropathology during Venezuelan equine encephalitis virus infection. J Gen Virol (2011) 0.78
Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype. J Virol (2014) 0.78
The 5' and 3' ends of alphavirus RNAs--Non-coding is not non-functional. Virus Res (2015) 0.77
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose. Proc Natl Acad Sci U S A (2016) 0.77
A novel self-replicating chimeric lentivirus-like particle. J Virol (2011) 0.76
Antibody preparations from human transchromosomic cows exhibit prophylactic and therapeutic efficacy versus Venezuelan equine encephalitis virus. J Virol (2017) 0.75
Identification of Interactions between Sindbis Virus Capsid Protein and Cytoplasmic vRNA as Novel Virulence Determinants. PLoS Pathog (2017) 0.75
FACS-optimized mutants of the green fluorescent protein (GFP). Gene (1996) 24.12
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 16.68
Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc Natl Acad Sci U S A (1994) 8.06
Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J (1998) 7.20
Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology (1991) 4.45
Antibody-mediated clearance of alphavirus infection from neurons. Science (1991) 3.70
Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology (1997) 3.62
Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet (1996) 2.72
The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology (1989) 2.72
Three-dimensional structure of a membrane-containing virus. Proc Natl Acad Sci U S A (1993) 2.71
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J Virol (1993) 2.69
Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J Virol (2000) 2.67
Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology (2000) 2.59
A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci U S A (1995) 2.57
An influenza A virus containing influenza B virus 5' and 3' noncoding regions on the neuraminidase gene is attenuated in mice. Proc Natl Acad Sci U S A (1991) 2.55
Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol (2000) 2.41
Functional equivalents of interferon-mediated signals needed for induction of an mRNA can be generated by double-stranded RNA and growth factors. EMBO J (1987) 2.40
Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology (1995) 2.14
Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology (1991) 2.13
The 5'-terminal sequences of the genomic RNAs of several alphaviruses. J Mol Biol (1983) 2.05
Deduced consensus sequence of Sindbis virus strain AR339: mutations contained in laboratory strains which affect cell culture and in vivo phenotypes. J Virol (1996) 1.88
Defined mutations in the 5' nontranslated sequence of Sindbis virus RNA. J Virol (1990) 1.87
Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America. Proc Natl Acad Sci U S A (1995) 1.83
Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus. J Virol (1997) 1.81
Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virology (1995) 1.79
A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J Virol (1996) 1.68
The comparative pathology of experimental Venezuelan equine encephalomyelitis infection in different animal hosts. J Infect Dis (1962) 1.68
Fatal Sindbis virus infection of neonatal mice in the absence of encephalitis. Virology (1996) 1.62
The role of antibody in recovery from alphavirus encephalitis. Immunol Rev (1997) 1.60
Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome. J Virol (1999) 1.56
Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Virology (1999) 1.55
The attenuation of poliovirus neurovirulence. Annu Rev Microbiol (1987) 1.42
Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC Venezuelan equine encephalitis viruses from an enzootic subtype ID progenitor. J Virol (1999) 1.36
Attenuation of Sindbis virus neurovirulence by using defined mutations in nontranslated regions of the genome RNA. J Virol (1992) 1.34
The use of chimeric Venezuelan equine encephalitis viruses as an approach for the molecular identification of natural virulence determinants. J Virol (2000) 1.32
A single base deletion in the 5' noncoding region of Theiler's virus attenuates neurovirulence. J Virol (1992) 1.30
Molecular analysis of neurovirulent strains of Sindbis virus that evolve during persistent infection of scid mice. J Virol (1993) 1.28
A single amino acid change in nsP1 attenuates neurovirulence of the Sindbis-group alphavirus S.A.AR86. J Virol (2000) 1.27
Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins. J Virol (1998) 1.23
Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse. Virology (2001) 1.21
The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease. J Virol (1991) 1.17
TNFalpha, interferon, and stress response induction as a function of age-related susceptibility to fatal Sindbis virus infection of mice. Virology (1999) 1.17
Control of Sindbis virus infection by antibody in interferon-deficient mice. J Virol (2000) 1.16
A single nucleotide change in the 5' noncoding region of Sindbis virus confers neurovirulence in rats. J Virol (1999) 1.11
Interferon induction and sensitivity as correlates to virulence of Venezuelan encephalitis viruses for hamsters. Arch Virol (1976) 1.07
Interferon-sensitive mutants of mengovirus. I. Isolation and biological characterization. Virology (1976) 1.06
Genetic determinants of Sindbis virus neuroinvasiveness. J Virol (1997) 1.01
Mutational analysis of a virulence locus in the E2 glycoprotein gene of Sindbis virus. J Virol (1991) 1.01
Interferon sensitivity of Venezuelan equine encephalomyelitis virus. Infect Immun (1973) 1.01
A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus. Virology (2000) 0.95
Infections of congenitally athymic (nude) and normal mice with avirulent and virulent strains of Venezuelan encephalitis virus. Infect Immun (1978) 0.91
Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophages. Microb Pathog (1996) 0.90
Sindbis virus pathogenesis: phenotypic reversion of an attenuated strain to virulence by second-site intragenic suppressor mutations. J Gen Virol (1993) 0.87
Sequencing of prototype viruses in the Venezuelan equine encephalitis antigenic complex. Virus Res (1999) 0.83
SVMPA, a mutant of sindbis virus resistant to mycophenolic acid and ribavirin, shows an increased sensitivity to chick interferon. Virology (1999) 0.83
Semliki Forest virus (A7[74]) infection of adult mice induces an immune-mediated demyelinating encephalomyelitis. Ann N Y Acad Sci (1988) 0.78
Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet (2001) 6.05
Diffraction enhanced x-ray imaging. Phys Med Biol (1997) 4.63
Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology (1997) 3.62
Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol (1998) 3.51
Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet (2000) 3.25
Properties of a ribonucleoprotein particle isolated from Nonidet P-40-treated Rous sarcoma virus. J Virol (1972) 3.25
N protein alone satisfies the requirement for protein synthesis during RNA replication of vesicular stomatitis virus. J Virol (1984) 3.00
Structural studies of avian myeloblastosis virus: comparison of polypeptides in virion and core component by dodecyl sulfate-polyacrylamide gel electrophoresis. J Virol (1974) 2.79
Three-dimensional structure of a membrane-containing virus. Proc Natl Acad Sci U S A (1993) 2.71
Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J Virol (2000) 2.67
Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology (2000) 2.59
Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol (2000) 2.41
Role of the nucleocapsid protein in regulating vesicular stomatitis virus RNA synthesis. Cell (1985) 2.38
Synthesis of vesicular stomatitis virus negative-strand RNA in vitro: dependence on viral protein synthesis. J Virol (1982) 2.28
Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology (1995) 2.14
Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology (1991) 2.13
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J Virol (2000) 2.09
Kin recognition and the 'armpit effect': evidence of self-referent phenotype matching. Proc Biol Sci (2000) 2.04
Vesicular stomatitis virus N and NS proteins form multiple complexes. J Virol (1986) 2.01
Sindbis virus mutants selected for rapid growth in cell culture display attenuated virulence in animals. Science (1984) 2.00
Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med (2000) 1.99
Molecular analysis of Sindbis virus pathogenesis in neonatal mice by using virus recombinants constructed in vitro. J Virol (1988) 1.96
In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant. Virology (1989) 1.93
A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg (1994) 1.92
Nutritional requirements of Plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth. J Protozool (1985) 1.91
Deduced consensus sequence of Sindbis virus strain AR339: mutations contained in laboratory strains which affect cell culture and in vivo phenotypes. J Virol (1996) 1.88
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens (1998) 1.83
A single nucleotide change in the E2 glycoprotein gene of Sindbis virus affects penetration rate in cell culture and virulence in neonatal mice. Proc Natl Acad Sci U S A (1986) 1.82
A conformational change in Sindbis virus glycoproteins E1 and E2 is detected at the plasma membrane as a consequence of early virus-cell interaction. J Virol (1990) 1.81
Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virology (1995) 1.79
Flow cytometry-based assay for titrating dengue virus. J Clin Microbiol (2005) 1.78
Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med (2001) 1.77
Sindbis virus mutations which coordinately affect glycoprotein processing, penetration, and virulence in mice. J Virol (1989) 1.75
Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J Virol (1997) 1.73
Changes in body composition after jejunoileal bypass in morbidity obese patients. Am J Surg (1972) 1.71
A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J Virol (1996) 1.68
Characterization of Sindbis virus epitopes important for penetration in cell culture and pathogenesis in animals. Virology (1986) 1.64
Fatal Sindbis virus infection of neonatal mice in the absence of encephalitis. Virology (1996) 1.62
Assembly of overlapping DNA sequences by a program written in BASIC for 64K CP/M and MS-DOS IBM-compatible microcomputers. Nucleic Acids Res (1986) 1.62
The importance and implementation of accurate 3D compensation methods for quantitative SPECT. Phys Med Biol (1994) 1.61
Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Virology (1995) 1.57
Conformational alteration of Sindbis virion glycoproteins induced by heat, reducing agents, or low pH. J Virol (1992) 1.56
Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome. J Virol (1999) 1.56
RNase III cleaves vesicular stomatitis virus genome-length RNAs but fails to cleave viral mRNA's. J Virol (1979) 1.50
Homologous interference induced by Sindbis virus. J Virol (1974) 1.49
Significance of perihematomal edema in acute intracerebral hemorrhage: the INTERACT trial. Neurology (2009) 1.44
Complete nucleotide sequence and full-length cDNA clone of S.A.AR86 a South African alphavirus related to Sindbis. Virology (1996) 1.41
Human breast cancer specimens: diffraction-enhanced imaging with histologic correlation--improved conspicuity of lesion detail compared with digital radiography. Radiology (2000) 1.39
Alternative forms of a strain-specific neutralizing antigenic site on the Sindbis virus E2 glycoprotein. Virology (1987) 1.38
[Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication]. Ned Tijdschr Geneeskd (2000) 1.38
Correlation of messenger RNA function with adenylate-rich segments in the genomes of single-stranded RNA viruses. Proc Natl Acad Sci U S A (1972) 1.36
Attenuating mutations in glycoproteins E1 and E2 of Sindbis virus produce a highly attenuated strain when combined in vitro. J Virol (1990) 1.36
Sindbis-group alphavirus replication in periosteum and endosteum of long bones in adult mice. J Virol (2000) 1.35
The furin protease cleavage recognition sequence of Sindbis virus PE2 can mediate virion attachment to cell surface heparan sulfate. J Virol (1999) 1.35
An adenylate-rich segment in the virion RNA of Sindbis virus. Biochem Biophys Res Commun (1972) 1.35
Structural rearrangement of infecting Sindbis virions at the cell surface: mapping of newly accessible epitopes. J Virol (1993) 1.34
Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens (2001) 1.30
Structural localization of the E3 glycoprotein in attenuated Sindbis virus mutants. J Virol (1998) 1.30
Requirement for host transcription in the replication of Sindbis virus. J Virol (1983) 1.30
Cell-free synthesis and assembly of vesicular stomatitis virus nucleocapsids. J Virol (1983) 1.28
Medical applications of diffraction enhanced imaging. Breast Dis (1998) 1.28
The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens (1997) 1.27
A single amino acid change in nsP1 attenuates neurovirulence of the Sindbis-group alphavirus S.A.AR86. J Virol (2000) 1.27
Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res (2011) 1.25
Contrast limited adaptive histogram equalization image processing to improve the detection of simulated spiculations in dense mammograms. J Digit Imaging (1998) 1.25
Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate. Virology (1997) 1.22
Analysis of T-cell-dependent and -independent antigens of Rickettsia conorii with monoclonal antibodies. Infect Immun (1987) 1.21
Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse. Virology (2001) 1.21
Introduction to perceptual linearization of video display systems for medical image presentation. J Digit Imaging (1995) 1.21
The causation of two scent-marking behaviour patterns in female hamsters (Mesocricetus auratus). Anim Behav (1977) 1.20
Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses. Virology (2000) 1.19
Lesions centered on the medial amygdala impair scent-marking and sex-odor recognition but spare discrimination of individual odors in female golden hamsters. Behav Neurosci (1999) 1.18
Prognostic markers of colorectal cancer: an evaluation of DNA content, epidermal growth factor receptor, and Ki-67. J Surg Oncol (1992) 1.18
TNFalpha, interferon, and stress response induction as a function of age-related susceptibility to fatal Sindbis virus infection of mice. Virology (1999) 1.17
Antigenic and genetic characterization of Sindbis virus monoclonal antibody escape mutants which define a pathogenesis domain on glycoprotein E2. Virology (1990) 1.17
Heme orientational disorder in reconstituted and native sperm whale myoglobin. Proton nuclear magnetic resonance characterizations by heme methyl deuterium labeling in the Met-cyano protein. J Mol Biol (1983) 1.16
A Sindbis virus variant with a cell-determined latent period. Virology (1981) 1.16
A method for determination of optimal image enhancement for the detection of mammographic abnormalities. J Digit Imaging (1994) 1.15
Sentinel lymph-node biopsy in breast cancer. Can J Surg (1999) 1.15
Image processing algorithms for digital mammography: a pictorial essay. Radiographics (2000) 1.15
Lethality of PE2 incorporation into Sindbis virus can be suppressed by second-site mutations in E3 and E2. J Virol (1994) 1.14
Radiologists' preferences for digital mammographic display. The International Digital Mammography Development Group. Radiology (2000) 1.14
How many screens does a CT workstation need? J Digit Imaging (1994) 1.12
Effect of display luminance on the feature detection rates of masses in mammograms. Med Phys (1999) 1.11
Effects of vomeronasal organ removal on individual odor discrimination, sex-odor preference, and scent marking by female hamsters. Physiol Behav (1999) 1.10
Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. Vaccine (2000) 1.08
A study of radiologists viewing multiple computed tomography examinations using an eyetracking device. J Digit Imaging (1990) 1.07
Hormonal and behavioral responses of male hamsters to females and female odors: roles of olfaction, the vomeronasal system, and sexual experience. Physiol Behav (1994) 1.06
Experience in the United States with intact abdominal aortic aneurysm repair. J Vasc Surg (2001) 1.06